HBV2023* et al. Highlights from the 2023 international meeting on the molecular biology of hepatitis B virus. J. Gen. Virol. 105:001978 (2024)
Steer, B. ; Adler, B.* & Adler, H. Open reading frames M12/M13 jointly contribute to MHV-68 latency. J. Gen. Virol. 104:8 (2023)
Olbrich, L.* et al. Head-to-head evaluation of seven different seroassays including direct viral neutralisation in a representative cohort for SARS-CoV-2. J. Gen. Virol. 102:001653 (2021)
Marschall, M.* et al. Differential upregulation of host cell protein kinases by the replication of α-, β- and γ-Herpesviruses provides a signature o virus-specific signalling. J. Gen. Virol. 101, 284-289 (2020)
D'Arienzo, V.* et al. A PCR assay to quantify patterns of HBV transcription. J. Gen. Virol. 102:001373 (2019)
de Sousa-Pereira, P. et al. The antiviral activity of rodent and lagomorph SERINC3 and SERINC5 is counteracted by known viral antagonists. J. Gen. Virol. 100, 278-288 (2019)
Ayoubian, H.* et al. Antibodies against the mono-methylated arginine-glycine repeat (MMA-RG) of the Epstein-Barr virus nuclear antigen 2 (EBNA2) identify potential cellular proteins targeted in viral transformation. J. Gen. Virol. 98, 2128-2142 (2017)
Meredith, L.W.* et al. Lentiviral hepatitis B pseudotype entry requires NTCP and additional hepatocyte-specific factors. J. Gen. Virol. 97, 121-127 (2016)
Yin, R.* et al. Expression of raf kinase inhibitor protein is down regulated in response to newcastle disease virus infection to promote viral replication. J. Gen. Virol. 96, 2579-2586 (2015)
Hesse, J.* et al. Suppression of CD8+ T cell recognition in the immediate-early phase of human cytomegalovirus infection. J. Gen. Virol. 94, 376-386 (2013)
Ohno, S. ; Steer, B. ; Sattler, C. & Adler, H. ORF23 of murine gammaherpesvirus 68 is non-essential for in vitro and in vivo infection. J. Gen. Virol. 93, 1076-1080 (2012)
Haupt, S. et al. Human endogenous retrovirus transcription profiles of the kidney and kidney-derived cell lines. J. Gen. Virol. 92, 2356-2366 (2011)
Ali, L.* et al. Patient HLA-DRB1* and -DQB1* allele and haplotype association with hepatitis C virus persistence and clearance. J. Gen. Virol. 91, 1931-1938 (2010)
Backes, S.* et al. Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation factor 2α. J. Gen. Virol. 91, 470-482 (2010)
Levin, A.* et al. A novel role for the viral Rev protein in promoting resistance to superinfection by human immunodeficiency virus type 1. J. Gen. Virol. 91, 1503-1513 (2010)
Roupelieva, M.* et al. Kaposi's sarcoma-associated herpesvirus Lana-1 is a major activator of the serum response element and mitogen-activated protein kinase pathways via interactions with the Mediator complex. J. Gen. Virol. 91, 1138-1149 (2010)
Grabusic, K. et al. The CR4 region of EBNA2 convers viability of Epstein-Barr virus-transformed B cells by CBF1-independent signalling. J. Gen. Virol. 87, 3169-3176 (2006)
Staib, C. ; Suezer, Y.* ; Kisling, S. ; Kalinke, U.* & Sutter, G.* Short-term, but not post-exposure, protection against lethal orthopoxvirus challenge after immunization with modified vaccinia virus Ankara. J. Gen. Virol. 87, 2917-2921 (2006)
Schaadt, E. ; Baier, B. ; Mautner, J. ; Bornkamm, G.W. & Adler, B.* Epstein-Barr virus latent membrane protein 2A mimics B-cell receptor-dependent virus reactivation. J. Gen. Virol. 86, 551-559 (2005)
Staib, C. ; Kisling, S. ; Erfle, V. & Sutter, G. Inactivation of the viral interleukin 1ß receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara. J. Gen. Virol. 86, 1997-2006 (2005)
Koopman, G.* et al. Vaccine protection from CD4⁺ T-cell loss caused by simian immunodeficiency virus (SIV) mac251 is afforded by sequential immunization with three unrelated vaccine vectors encoding multiple SIV antigens. J. Gen. Virol. 85, 2915-2924 (2004)
Mäkitalo, B.* ; Sutter, G. & Erfle, V. Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen. J. Gen. Virol. 85, 2407-2419 (2004)
Nimmerjahn, F. et al. Active NF-kB signalling is a prerequisite for influenza virus infection. J. Gen. Virol. 85, 2347-2356 (2004)
Simas, J.P.* ; Marques, S.* ; Bridgeman, A.* ; Efstathiou, S.* & Adler, H. The M2 gene product of murine gammaherpesvirus 68 is required for efficient colonization of splenic follicles but is not necessary for expansion of latently infected germinal centre B cells. J. Gen. Virol. 85, 2789-2797 (2004)
Meiser, A. ; Boulanger, D. ; Sutter, G. & Krijnse Locker, J.* Comparison of virus production in chicken embryo fibroblasts infected with the WR, IHD-J and  MVA strains of vaccinia virus : IHD-J is most efficient in trans-Golgi network wrapping and extracellular eveloped virus release. J. Gen. Virol. 84, 1383-1392 (2003)
Nilsson, C.* et al. Immunization with recombinant modified vaccinia virus Ankara can modify mucosal simian  immunodeficiency virus infection and delay disease progression in macaques. J. Gen. Virol. 83, 807-818 (2002)
Wachinger, M. et al. Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression. J. Gen. Virol. 79, 731-740 (1998)
Brielmeier, M. ; Mautner, J. ; Laux, G. & Hammerschmidt, W. The latent membrane protein 2 gene of Epstein-Barr virus is important for efficient B cell immortalization. J. Gen. Virol. 77, 2807-2818 (1996)
Faff, O. et al. Retrovirus-like Particles from the hum T47D Cell Line are Related to Mouse Mmary Tumour Virus and are of Human Endogenous Origin. J. Gen. Virol. 73, 1087-1097 (1992)
Kirchner, E.A. ; Bornkamm, G.W. & Polack, A. Transcriptional Acitvity Across the Epstein-Barr Virus Genome in Raji Cells During Latency and After Induction of an Abortive Lytic Cycle. J. Gen. Virol. 72, 2391-2398 (1991)
Laux, G. ; Economou, A. & Farrell, P.J. The Terminal Protein Gene 2 of Epstein-Barr Virus Is Transcribed from a Bidirectional Latent Promoter Region. J. Gen. Virol. 70, 3079-3084 (1989)
Auling, G. ; Bernard, U. ; Huettermann, A. & Mayer, F.C. Characterization and comparison of the DNAs of the three closely related bacteriophages gd, ge and gf with the genome DNA of the hydrogen-oxidizing host strain Pseudomonas pseudoflava GA3. J. Gen. Virol. 49, 51-59 (1980)